| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/20/2007 | US20070292414 Compositions enriched in neoplastic stem cells and methods comprising same |
| 12/20/2007 | US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 12/20/2007 | US20070292412 Novel genes and markers in type 2 diabetes and obesity |
| 12/20/2007 | US20070292411 Antibodies That Immunospecifically Bind to TRAIL Receptors |
| 12/20/2007 | US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders |
| 12/20/2007 | US20070292409 Identifying modulators of G protein-coupled receptor kinase 2 (GRK2); treatment and prevention of type 2 diabetes mellitus and insulin resistance in humans |
| 12/20/2007 | US20070292390 Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies |
| 12/20/2007 | US20070292389 Method for the Purification and Amplification of Tumoral Stem Cells |
| 12/20/2007 | US20070292388 In vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells in medium comprising ligands of EGF receptor and GP130 receptor, such as EGF and LIF; insulin secreting cells obtainable by this method provide means for treatment of diabetes |
| 12/20/2007 | US20070292386 Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents |
| 12/20/2007 | US20070292348 Treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6 |
| 12/20/2007 | US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases |
| 12/20/2007 | US20070292346 Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk |
| 12/19/2007 | EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 12/19/2007 | EP1867661A1 Compositions and methods for delivering anti-activated ras antibodies into cells |
| 12/19/2007 | EP1866342A2 Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation |
| 12/19/2007 | EP1866339A2 Gitr binding molecules and uses therefor |
| 12/19/2007 | EP1866338A1 Antibodies against cd38 for treatment of multiple myeloma |
| 12/19/2007 | EP1866336A2 Neutralizing antibodies and methods of use thereof |
| 12/19/2007 | EP1866326A2 Immunogens for vaccines against antigenically variable pathogens and diseases |
| 12/19/2007 | EP1865987A2 Inhibition of p-glycoprotein by treatment with a class of modulators and the uic2 monoclonal antibody |
| 12/19/2007 | EP1865986A2 Anti-ctla-4 antibody compositions |
| 12/19/2007 | EP1865985A2 Kim-1 antibodies for treatment of th2-mediated conditions |
| 12/19/2007 | EP1865984A1 Immunogenic compositions comprising lawsonia intracellularis |
| 12/19/2007 | EP1865974A1 Combination consisting of a histological or cytological fixing solution and of one or more photoactivatable compounds of the family of quinones, in particular, hypericin, hypocrellin a and hyprcrellin b |
| 12/19/2007 | EP1597376B1 Chicken rna polymerase i promoter and the use thereof |
| 12/19/2007 | EP1416965B1 Assay method for alzheimer's disease |
| 12/19/2007 | EP1311540B1 Altered ospa of borrelia burgdorferi |
| 12/19/2007 | EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | EP1194166B1 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/19/2007 | EP1091757B1 Alpha emitting constructs and uses thereof |
| 12/19/2007 | EP1090033B2 Particles of hcv envelope proteins: use for vaccination |
| 12/19/2007 | EP0772689B1 Retroviral vectors having a reduced recombination rate |
| 12/19/2007 | EP0519001B2 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 12/19/2007 | CN101090974A Multivalent vaccines comprising recombinant viral vectors |
| 12/19/2007 | CN101090966A Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 12/19/2007 | CN101090913A Antibodies against tenascin-c |
| 12/19/2007 | CN101090912A Torc polynucleotides and polypeptides, and methods of use |
| 12/19/2007 | CN101090734A Remedy for endometriosis |
| 12/19/2007 | CN101089180A Recombination LFA3 gene, and its mixed gene and product |
| 12/19/2007 | CN101089177A Type II genetic marker strain of porcine circovirus and its application |
| 12/19/2007 | CN101088561A Anti hepatitis c virus antibody and uses thereof |
| 12/19/2007 | CN101088560A Antigenic composite, multi-clone antibody prepared by it and its application |
| 12/19/2007 | CN101088559A Polyepitope tuberculosis gene vaccine and its prepn process |
| 12/19/2007 | CN101088496A Microecological bifid bacterium signal molecule prepn and its prepn process |
| 12/19/2007 | CN100355882C Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody |
| 12/19/2007 | CN100355881C Plant expression carrier plasmid for hepatitis B gene, hepatitis B gene transgenic cell line and its industrialization production application |
| 12/19/2007 | CN100355785C Process for selectively separating IgY antibody from anseriforme birds eggs and IgY antibody produced therefrom |
| 12/19/2007 | CN100355781C 肽 Peptide |
| 12/19/2007 | CN100355777C Hepatitis B virus pre-S mutain, and its preparing process and application |
| 12/19/2007 | CN100355454C Nano-magnetic powder antihuman lirer cancer single anti HAb18 target medicine for magnetic heat therapy |
| 12/19/2007 | CN100355453C Improved vaccines |
| 12/18/2007 | US7309784 multicomponent vaccine; immunogenic polypeptide that contains a membrane translocating sequence, to facilitate introduction of the polypeptide into the mammalian cell and subsequent stimulation of the cell-mediated immune response; Chagas' disease |
| 12/18/2007 | US7309778 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/18/2007 | US7309776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 12/18/2007 | US7309775 Membrane binding protein; central nervous system disorders, Alzheimer's disease, Parkinson's disease |
| 12/18/2007 | US7309761 Membrane bound proteins; genetic engineering; libraries |
| 12/18/2007 | US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 12/18/2007 | US7309598 gM-negative EHV-mutants |
| 12/18/2007 | US7309583 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals |
| 12/18/2007 | US7309495 For immunizing a cat against a hemorrhagic feline calicivirus (hFCV) |
| 12/18/2007 | US7309494 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |
| 12/18/2007 | US7309493 Inactivated bovine scours vaccines, process and method of preventing bovine scours |
| 12/18/2007 | US7309492 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus |
| 12/18/2007 | US7309491 Heat shock protein-based vaccines and immunotherapies |
| 12/18/2007 | US7309490 Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response |
| 12/18/2007 | US7309489 Monoclonal antibody that binds to mouse CD40L; inhibit CD40-L or anti-CD40 mAb induced B cell stimulation, IL-4-induced IgE stimulation and IL-4 induced CD23 induction in B cells |
| 12/18/2007 | US7309488 capable of efficient and selective adsorption of an antibody against beta 1-adrenoceptor and/or an antibody against M2 muscarinic receptor occurring in a body fluid (e.g. blood, plasma or the like) without requiring a pretreatment |
| 12/18/2007 | US7309487 Administering antibody that specifically binds to a matrix metalloproteinase membrane-associated 1 (MT1-MMP) protein for therapy of age-related macular degeneration |
| 12/18/2007 | US7309486 HER cancer protocols |
| 12/18/2007 | US7309485 Oligodendrocyte-myelin glycoprotein (OMgp)-specific binding agents, receptor binding assays; promoting nerve fiber growth |
| 12/18/2007 | US7309483 Reducing pathological neovascularization in a human by administering to the human an agent capable of interfering with Ang2-mediated biological effects |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2249390C Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/18/2007 | CA2233042C Specific binding members for human transforming growth factor beta; materials and methods |
| 12/18/2007 | CA2062047C Fusion proteins for prodrug activation, the preparation and use thereof |
| 12/18/2007 | CA1341566C Immune response to tumors induced by anti-idiotype antibodies |
| 12/14/2007 | CA2549124A1 Method and a kit for the detection of adenoviruses |
| 12/13/2007 | WO2007143689A2 Compositions and methods for modulating vascular development |
| 12/13/2007 | WO2007143600A2 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 12/13/2007 | WO2007143442A2 A novel virulence determinant within the e2 structural glycoprotein of classical swine fever virus |
| 12/13/2007 | WO2007143212A1 Capecitabine combination therapy |
| 12/13/2007 | WO2007143174A2 Combination therapy method and formulation |
| 12/13/2007 | WO2007143104A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 12/13/2007 | WO2007143098A2 Hepatocyte growth factor (hgf) binding proteins |
| 12/13/2007 | WO2007143023A1 Soluble endoglin compounds and uses thereof for the treatment and prevention of cancer |
| 12/13/2007 | WO2007143004A2 Methods, compositions, and kits for treating shiga toxin associated conditions |
| 12/13/2007 | WO2007142781A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 12/13/2007 | WO2007142667A2 Treatment of patients with autoantibody positive disease |
| 12/13/2007 | WO2007142325A1 Preventive or remedy for inflammatory disease |
| 12/13/2007 | WO2007142277A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | WO2007142241A1 Immunocompetent cell having anti-cd38 antibody on its cell surface |
| 12/13/2007 | WO2007141274A2 Human binding molecules having killing activity against staphylococci and uses thereof |
| 12/13/2007 | WO2007141259A1 Live attenuated dengue 3 virus strains |
| 12/13/2007 | WO2007141043A2 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 12/13/2007 | WO2007141029A1 Specific protease inhibitors and their use in cancer therapy |
| 12/13/2007 | WO2007141005A1 Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007141004A1 Use of adipsin (adn) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007140953A1 Peptide associated with rheumatic fever (parf) and its use as a diagnostic marker |